Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy

Area of Science:

• Gerontology and Regenerative Medicine
• Immunology and Bone Biology
• Biomaterials and Tissue Engineering

Background:

• Global population aging increases osteoporosis and fragility fractures, impacting quality of life and healthcare costs.
• Aging is characterized by inflammaging, a chronic, low-level systemic inflammation that impairs bone regeneration.
• Dysfunctional macrophage repolarization (M1 to M2) in inflammaging leads to increased bone resorption and decreased formation.

Purpose of the Study:

• To review the bone regeneration process in the context of inflammaging.
• To explore immunomodulatory therapies for enhancing bone healing in the elderly.
• To highlight the role of mesenchymal stem cells (MSCs) in addressing age-related bone healing deficits.

Main Methods:

• Review of current literature on bone regeneration, inflammaging, and immunomodulation.
• Analysis of macrophage polarization dynamics during aging and inflammation.
• Examination of MSC-based therapies, including preconditioning, hypoxia, and exosomes, for bone regeneration.

Main Results:

• Inflammaging disrupts the normal inflammatory response, hindering the initiation of bone healing.
• Failure in M1 to M2 macrophage repolarization contributes to an imbalance favoring bone resorption over formation.
• MSCs and their exosomes demonstrate immunomodulatory and regenerative potential for improving bone healing in inflammaging.

Conclusions:

• Inflammaging significantly impairs bone regeneration in the elderly population.
• Targeting and modulating inflammaging presents a viable therapeutic avenue for enhancing bone health and healing.
• MSC-based strategies and anti-inflammatory approaches hold promise for treating age-related bone healing complications.